{"id":"W4390399052","doi":"10.1016/j.ahj.2023.12.004","title":"Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial","year":2023,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Amgen","keywords":"Evolocumab; Medicine; Internal medicine; Stroke (engine); Myocardial infarction; Cardiology; Clinical endpoint; PCSK9; Population; Randomized controlled trial; Apolipoprotein B; Cholesterol; Lipoprotein; Apolipoprotein A1","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04742118,0.003842177,0.006073802,0.001251996,0.001865212,0.003796899,0.002364614,0.004298218,0.01027271],"category_scores_gemma":[0.02990393,0.002348162,0.00396161,0.000984563,0.005052727,0.002062513,0.001904918,0.006880672,0.003209148],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001679835,"about_ca_system_score_gemma":0.005637072,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005883477,"about_ca_topic_score_gemma":0.0008500427,"domain_scores_codex":[0.9668254,0.02511532,0.001956778,0.002531724,0.002051617,0.00151913],"domain_scores_gemma":[0.9905406,0.003656555,0.001424147,0.001470446,0.0009220089,0.001986249],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8628716,0.005033135,0.007761938,0.006200408,0.006696348,0.0003863688,0.0004684622,0.002982868,0.003223835,0.03344483,0.0111276,0.05980265],"study_design_scores_gemma":[0.8802941,0.03440215,0.009370364,0.001890087,0.00605574,0.0002697877,0.0001502855,0.004219757,0.00175245,0.02398392,0.0373835,0.000227841],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.1963012,0.04532838,0.0519423,0.03010363,0.01474275,0.5984788,0.01396598,0.0007531914,0.04838373],"genre_scores_gemma":[0.4689766,0.004875901,0.05976089,0.01695807,0.005226684,0.4349324,0.00242574,0.0001429988,0.006700784],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.04742118,"threshold_uncertainty_score":0.2507902,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01322032159210375,"score_gpt":0.2639724303145022,"score_spread":0.2507521087223984,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}